Carregant...
Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate
The intensity of bone remodeling is a critical determinant of the decay of cortical and trabecular microstructure after menopause. Denosumab suppresses remodeling more than alendronate, leading to greater gains in areal bone mineral density (aBMD). These greater gains may reflect differing effects o...
Guardat en:
| Publicat a: | J Bone Miner Res |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley Subscription Services, Inc., A Wiley Company
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445722/ https://ncbi.nlm.nih.gov/pubmed/20222106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.81 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|